Read + Share
Minczeles NS, de Herder WW, Konijnenberg MW, Feelders RA, et al. Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy
Are More Prevalent in Women Than in Men. Clin Nucl Med 2022;47:599-605.
PMID: 35426841
|
 |
|
Minczeles NS, de Herder WW, Konijnenberg MW, Feelders RA, et al. Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy
Are More Prevalent in Women Than in Men. Clin Nucl Med 2022;47:599-605.
PMID: 35426841
|
|
|
|